Methoden vergleichen

	Medikationsadhärenz-Bewertungsskala (MARS)	Fragebogen zu Medikamentenüberzeugungen (BMQ)
Fachgebiet	Pharmakologie	Pharmakologie
Familie	Process / pipeline	Process / pipeline
Entstehungsjahr	2000	1999
Urheber	Kathryn Thompson, Jayashri Kulkarni, and Anthony A. Sergejew	Rob Horne, John Weinman, and Michelle Hankins
Typ	Self-report	Self-report
Wegweisende Quelle	Thompson, K., Kulkarni, J., & Sergejew, A. A. (2000). Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research, 42(3), 241-247.	Horne, R., Weinman, J., & Hankins, M. (1999). The Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1-24.
Aliasnamen	MARS	BMQ
Verwandt	4	4
Zusammenfassung	The Medication Adherence Rating Scale (MARS) is a 10-item self-report measure developed by Thompson, Kulkarni, and Sergejew in 2000 to assess medication adherence behaviors and attitudes in psychiatric populations, particularly antipsychotic medication use. Although originally validated in schizophrenia, it has been successfully applied across diverse medical conditions including hypertension, diabetes, and chronic disease management, providing a quick, sensitive assessment of actual adherence frequency and admission of problematic medication-taking behaviors.	The Beliefs about Medicines Questionnaire (BMQ) is an 18-item self-report measure developed by Horne, Weinman, and Hankins in 1999 to assess patients' cognitive beliefs about necessity of medications and concerns about potential adverse effects. It is widely used in clinical research to predict medication adherence, particularly in chronic disease management, and has demonstrated strong predictive validity across diverse populations and disease contexts.